Antileukemic Efficacy in Vitro of Talazoparib and APE1 Inhibitor III Combined with Decitabine in Myeloid Malignancies

Malignant hematopoietic cells of myelodysplastic syndromes (MDS)/chronic myelomonocytic leukemias (CMML) and acute myeloid leukemias (AML) may be vulnerable to inhibition of poly(ADP ribose) polymerase 1/2 (PARP1/2) and apurinic/apyrimidinic endonuclease 1 (APE1). PARP1/2 and APE1 are critical enzym...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Kohl, Vanessa, Flach, Johanna, Naumann, Nicole, Brendel, Susanne, Kleiner, Helga, Weiss, Christel, Seifarth, Wolfgang, Nowak, Daniel, Hofmann, Wolf-Karsten, Fabarius, Alice, Popp, Henning D.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6826540/
https://ncbi.nlm.nih.gov/pubmed/31623402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11101493
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados